Skandinaviska Enskilda Banken (SEB)’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $518K | Hold |
16,400
| – | – | ﹤0.01% | 700 |
|
|
2025
Q1 | $544K | Buy |
+16,400
| New | +$544K | ﹤0.01% | 679 |
|
|
2024
Q4 | – | Sell |
-12,700
| Closed | -$508K | – | 852 |
|
|
2024
Q3 | $508K | Buy |
+12,700
| New | +$508K | ﹤0.01% | 714 |
|
|
2023
Q4 | – | Sell |
-25,947
| Closed | -$850K | – | 943 |
|
|
2023
Q3 | $850K | Hold |
25,947
| – | – | 0.01% | 701 |
|
|
2023
Q2 | $913K | Hold |
25,947
| – | – | 0.01% | 714 |
|
|
2023
Q1 | $847K | Sell |
25,947
-1,234
| -5% | -$40.3K | 0.01% | 708 |
|
|
2022
Q4 | $1.5M | Sell |
27,181
-1,574
| -5% | -$86.7K | 0.01% | 596 |
|
|
2022
Q3 | $1.27M | Hold |
28,755
| – | – | 0.01% | 629 |
|
|
2022
Q2 | $1.4M | Hold |
28,755
| – | – | 0.01% | 648 |
|
|
2022
Q1 | $1.4M | Buy |
28,755
+9,954
| +53% | +$484K | 0.01% | 691 |
|
|
2021
Q4 | $814K | Buy |
+18,801
| New | +$814K | ﹤0.01% | 800 |
|